Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07465913) titled 'Rocklatan vs Latanoprost Post-DSLT' on March 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Eye Centers of Southeast Texas
Condition:
Glaucoma
Intervention:
Drug: Rocklatan 0.02%-0.005% Ophthalmic Solution
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: May 6, 2026
Target Sample Size: 36
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07465913
Published...